Cutaneous reactions to transdermal therapeutic systems

Andrea Bershow, Erin Warshaw

Research output: Contribution to journalReview articlepeer-review

13 Scopus citations

Abstract

Transdermal therapeutic systems (TTSs) are commonly used to treat many diverse medical conditions. There are several advantages to this form of drug delivery; however, adverse cutaneous reactions are common. This review article provides an update on skin reactions due to TTSs containing medications newly available in TTS form, including buprenorphine, diclofenac, lidocaine, oxybutynin, rotigotine, methylphenidate, rivastigmine, teriparatide, and nicardipine.

Original languageEnglish (US)
Pages (from-to)193-203
Number of pages11
JournalDermatitis
Volume22
Issue number4
DOIs
StatePublished - Jul 1 2011

Fingerprint Dive into the research topics of 'Cutaneous reactions to transdermal therapeutic systems'. Together they form a unique fingerprint.

Cite this